Endothelial cell tropism in the pathogenesis and host response against influenza viruses - Resubmission 01
Endothelial cell tropism in the pathogenesis and host response against influenza viruses - Resubmission 01
批准号:
10303023
负责人:
Balaji Manicassamy
金额:
$54.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-08 至 2023-11-30
关键词:
Acute Respiratory Distress SyndromeAdultAntiviral ResponseAttenuated VaccinesAvian Influenza A VirusBiological ModelsBlood VesselsCell Adhesion MoleculesCellsCharacteristicsCoculture TechniquesDevelopmentDiseaseDisease ProgressionDown-RegulationElderlyEndothelial CellsEndotheliumEngineeringEpidemicEpithelial CellsExtravasationFerretsGenerationsGoalsHealthHematopoieticHumanImmuneImmune responseImmunocompromised HostIndividualInfectionInflammatoryInflammatory ResponseInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza A Virus, H7N7 SubtypeInfluenza A Virus, H7N9 SubtypeInfluenza A virusInjuryInnate Immune ResponseIntegration Host FactorsKnowledgeLinkLower respiratory tract structureLungMediatingMicroRNAsModelingMolecularMorbidity - disease rateMusNatureNeutrophil InfiltrationNosePathogenesisPathogenicityPositioning AttributePredispositionProductionPulmonary EdemaReporterReportingResearch PersonnelRoleSeverity of illnessSiteSurvival RateSymptomsTestingTherapeuticTransgenic OrganismsTropismUpper Respiratory InfectionsVascular PermeabilitiesViralViral GenesViral GenomeViral Load resultViral PathogenesisViral PneumoniaVirulenceVirulentVirusVirus DiseasesVirus ReplicationVulnerable Populationsage groupburden of illnesscell typecytokineexperimental studyimmunopathologyimprovedin vivoinfluenza infectioninfluenza virus straininfluenzaviruslung injurymembermonocytemortalitymouse modelneutrophilnovelnovel therapeutic interventionpandemic diseasepathogenpreventrational designrecombinant virusrecruitseasonal influenzatissue tropismtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Influenza A viruses pose a serious threat to human health, causing seasonal epidemics and occasional
pandemics that result in significant morbidity and mortality worldwide. The virulence and pathogenic nature of
influenza virus strains vary greatly, and is often determined by the constellation of viral genes. While seasonal
influenza viruses cause a mild upper respiratory infection in healthy individuals, highly pathogenic avian
influenza viruses (HPAIV) of the H5N1 subtype replicate in the lower respiratory tract, causing fatal viral
pneumonia characterized by pulmonary edema and vascular leakage. In addition, H5N1 infections are
associated with an uncontrolled activation of host immune responses, which contributes to the severity of
disease. The role of viral and host factors in the enhanced virulence and pulmonary immunopathology
characteristic of HPAIV infections remain unknown. To this end, we engineered H5N1 viruses with restricted
tropism through the incorporation of microRNA (miRNA) target sites into the viral genome. Specifically, we
generated an H5N1 virus carrying endothelial cell specific miR-126 target sites (H5N1-126T), such that viral
replication was abrogated in endothelial cells without impeding replication in other cell types. In our recent
studies, H5N1-126T infected mice and ferrets showed significantly reduced virulence and vascular leakage in
the lungs as compared to the control H5N1-ScrbT virus infected group, despite similar viral loads in the lungs
of mice and nasal washes of ferrets. To our knowledge, this is the first study to demonstrate the importance of
endothelial cell tropism to H5N1 pathogenesis. The current proposal will (1) determine the consequence of
endothelial cell infection to barrier integrity and function, (2) investigate the role of endothelial cell tropism in
orchestrating immune responses, and (3) assess the contribution of viral tropism to the pathogenesis of other
highly virulent strains including H7N7, 1918 H1N1, and H7N9 in mice and ferrets. The knowledge gained from
these studies will help to elucidate the mechanism by which virulent influenza viruses cause severe disease
and aid in the development of novel therapeutic strategies against virulent influenza strains. Furthermore,
these studies will reveal how viral tropism modulates host antiviral responses and will pave the way for the
rational design of novel live attenuated vaccines with restricted tropism.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.celrep.2018.03.045
发表时间:
2018-04-10
期刊:
Cell reports
影响因子:
8.8
作者:
[Han J, Perez JT, Chen C, Li Y, Benitez A, Kandasamy M, Lee Y, Andrade J, tenOever B, Manicassamy B]
通讯作者:
Manicassamy B
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.
针对流感病毒的广泛保护策略:通用疫苗和治疗方法。
DOI:
10.3389/fmicb.2020.00135
发表时间:
2020
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Vogel,OliviaA, Manicassamy,Balaji]
通讯作者:
Manicassamy,Balaji
DOI:
10.1128/jvi.01837-21
发表时间:
2022-02-09
期刊:
Journal of virology
影响因子:
5.4
作者:
[Malicoat J, Manivasagam S, Zuñiga S, Sola I, McCabe D, Rong L, Perlman S, Enjuanes L, Manicassamy B]
通讯作者:
Manicassamy B
DOI:
10.1371/journal.ppat.1006270
发表时间:
2017-03
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Tundup S, Kandasamy M, Perez JT, Mena N, Steel J, Nagy T, Albrecht RA, Manicassamy B]
通讯作者:
Manicassamy B
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
-
批准号:10874145
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2022
-
负责人:Balaji Manicassamy
-
依托单位:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
-
批准号:10671677
-
项目类别:
-
资助金额:$54.75万
-
财政年份:2022
-
负责人:Balaji Manicassamy
-
依托单位:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
-
批准号:10539709
-
项目类别:
-
资助金额:$54.75万
-
财政年份:2022
-
负责人:Balaji Manicassamy
-
依托单位:
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01
-
批准号:9769437
-
项目类别:
-
资助金额:$55.63万
-
财政年份:2017
-
负责人:Balaji Manicassamy
-
依托单位:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
-
批准号:9083899
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2016
-
负责人:Balaji Manicassamy
-
依托单位:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
-
批准号:9472173
-
项目类别:
-
资助金额:$1.66万
-
财政年份:2016
-
负责人:Balaji Manicassamy
-
依托单位:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
-
批准号:9925203
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2016
-
负责人:Balaji Manicassamy
-
依托单位:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
-
批准号:9086232
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2015
-
负责人:Balaji Manicassamy
-
依托单位:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
-
批准号:8956083
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2015
-
负责人:Balaji Manicassamy
-
依托单位:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
-
批准号:9090008
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2015
-
负责人:Balaji Manicassamy
-
依托单位:
Role of Pattern Recognition Receptors in Protection Against Influenza Virus
-
批准号:8610233
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2011
-
负责人:Balaji Manicassamy
-
依托单位:
Role of Pattern Recognition Receptors in Protection Against Influenza Virus
-
批准号:8604497
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Balaji Manicassamy
-
依托单位:
Role of Pattern Recognition Receptors in Protection Against Influenza Virus
-
批准号:8164891
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2011
-
负责人:Balaji Manicassamy
-
依托单位:
海外基金